{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T06:40:22Z","timestamp":1734331222841,"version":"3.30.2"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1990,1,1]],"date-time":"1990-01-01T00:00:00Z","timestamp":631152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[1990,1]]},"DOI":"10.1016\/0168-8227(90)90005-e","type":"journal-article","created":{"date-parts":[[2004,4,28]],"date-time":"2004-04-28T12:30:48Z","timestamp":1083155448000},"page":"23-35","source":"Crossref","is-referenced-by-count":10,"title":["The relevance of persistent C-peptide secretion in type 1 (insulin-dependent) diabetes mellitus to glycaemic control and diabetic complications"],"prefix":"10.1016","volume":"9","author":[{"given":"Peter H.","family":"Winocour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Jeacock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parmamjeet","family":"Kalsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0168-8227(90)90005-E_BIB1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2337\/diacare.1.3.168","article-title":"Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973","volume":"1","author":"Pirart","year":"1978","journal-title":"Diabetes Care"},{"key":"10.1016\/0168-8227(90)90005-E_BIB2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00421230","article-title":"Relation of diabetic control to development of microvascular complications","volume":"15","author":"Tchobroutsky","year":"1978","journal-title":"Diabetologia"},{"key":"10.1016\/0168-8227(90)90005-E_BIB3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0161-6420(84)34235-X","article-title":"The association between long-term diabetic control and early retinopathy","volume":"91","author":"Doft","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/0168-8227(90)90005-E_BIB4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF00276992","article-title":"Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes","volume":"28","author":"Hasslacher","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/0168-8227(90)90005-E_BIB5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF02427086","article-title":"Progression of subclinical polyneuropathy in young patients with type 1 (insulin-dependent) diabetes: associations with glycaemic control and microangiopathy (microvascular complications)","volume":"29","author":"Young","year":"1986","journal-title":"Diabetologia"},{"key":"10.1016\/0168-8227(90)90005-E_BIB6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/BF00870275","article-title":"Diabetic control and microvascular complications: the near-normoglycaemic experience","volume":"28","author":"Hanssen","year":"1986","journal-title":"Diabetologia"},{"key":"10.1016\/0168-8227(90)90005-E_BIB7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diacare.10.1.1","article-title":"Diabetes control and complications trial (DCCT): Results of feasibility study","volume":"10","year":"1987","journal-title":"Diabetes Care"},{"key":"10.1016\/0168-8227(90)90005-E_BIB8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2337\/diacare.6.4.361","article-title":"The role of circulating glucose and triglyceride concentrations and their interaction with other risk factors as determinants of arterial disease in nine diabetic population samples from the WHO Multinational Study","volume":"6","author":"West","year":"1983","journal-title":"Diabetes Care"},{"key":"10.1016\/0168-8227(90)90005-E_BIB9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.0954-6820.1983.tb08549.x","article-title":"Factors of importance for residual beta-cell function in type 1 diabetes mellitus","volume":"671","author":"Madsbad","year":"1983","journal-title":"Acta Med. Scand."},{"key":"10.1016\/0168-8227(90)90005-E_BIB10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2337\/diab.26.8.717","article-title":"Studies on the etiology of brittle diabetes. Relation between diabetic instability and insulinogenic reserve","volume":"26","author":"Shima","year":"1977","journal-title":"Diabetes"},{"key":"10.1016\/0168-8227(90)90005-E_BIB11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0022-3476(77)80762-2","article-title":"Control of juvenile diabetes and its relationship to endogenous insulin secretion as measured by C-peptide immunoreactivity","volume":"90","author":"Grajwer","year":"1977","journal-title":"J. Pediatr."},{"key":"10.1016\/0168-8227(90)90005-E_BIB12","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2337\/diabetes.28.8.749","article-title":"Metabolic control in diabetic patients. Effect of insulin-secretory reserve (measured by C-peptide levels) and circulating insulin antibodies","volume":"28","author":"Gonen","year":"1979","journal-title":"Diabetes"},{"key":"10.1016\/0168-8227(90)90005-E_BIB13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00251274","article-title":"The relationship between residual insulin secretion and metabolic stability in type 1 (insulin-dependent) diabetes","volume":"21","author":"Lutterman","year":"1981","journal-title":"Diabetologia"},{"key":"10.1016\/0168-8227(90)90005-E_BIB14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2337\/diacare.5.4.399","article-title":"Metabolic control in 131 juvenile onset diabetic patients as measured by HbA1: Relation to age, duration, C-peptide, insulin-dose and one or two injections","volume":"5","author":"Dahlquist","year":"1982","journal-title":"Diabetes Care"},{"key":"10.1016\/0168-8227(90)90005-E_BIB15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF00270417","article-title":"Residual insulin production, glycaemic control and the prevalence of microvascular lesions and polyneuropathy in long term type 1 (insulin-dependent) diabetes mellitus","volume":"30","author":"Sjoberg","year":"1987","journal-title":"Diabetologia"},{"key":"10.1016\/0168-8227(90)90005-E_BIB16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1210\/jcem-65-1-30","article-title":"Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual B cell function; observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT)","volume":"65","year":"1987","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/0168-8227(90)90005-E_BIB17","first-page":"351","article-title":"B-cell function of insulin-dependent young onset diabetics assessed by C-peptide immunoreactivity","volume":"11","author":"Ikeda","year":"1975","journal-title":"Diabetologia"},{"key":"10.1016\/0168-8227(90)90005-E_BIB18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00421234","article-title":"Persistent insulin secretion, assessed by plasma C-peptide estimation, in long term juvenile diabetics with a low insulin requirement","volume":"15","author":"Eff","year":"1978","journal-title":"Diabetologia"},{"key":"10.1016\/0168-8227(90)90005-E_BIB19","first-page":"265","article-title":"Plasma C-peptide in long standing type 1 diabetes with and without microvascular disease","volume":"7","author":"Bodansky","year":"1981","journal-title":"Diabetes Metab."},{"key":"10.1016\/0168-8227(90)90005-E_BIB20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00250151","article-title":"Prevalence of residual B-cell function and its metabolic consequences in type 1 (insulin-dependent) diabetes","volume":"24","author":"Madsbad","year":"1983","journal-title":"Diabetologia"},{"key":"10.1016\/0168-8227(90)90005-E_BIB21","first-page":"151","article-title":"Circulating C-peptide and diabetic retinopathy","volume":"1","author":"Moier","year":"1984","journal-title":"Diabetes Res."},{"key":"10.1016\/0168-8227(90)90005-E_BIB22","first-page":"304","article-title":"C-peptide response to glucagon in diabetes with and without microvascular disease","volume":"89","author":"Smith","year":"1987","journal-title":"N.Z. Med. J."},{"key":"10.1016\/0168-8227(90)90005-E_BIB23","first-page":"237","article-title":"Atherosclerotic vascular disease in middle-aged, insulin-treated diabetic patients. Association with endogenous insulin secretion capacity","volume":"8","author":"Ronnemaa","year":"1988","journal-title":"Atherosclerosis"},{"key":"10.1016\/0168-8227(90)90005-E_BIB24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.0954-6820.1983.tb08548.x","article-title":"Methodical aspects on C-peptide measurements","volume":"671","author":"Ludvigsson","year":"1983","journal-title":"Acta Med. Scand."},{"key":"10.1016\/0168-8227(90)90005-E_BIB25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0009-8981(86)90212-3","article-title":"Precise measurement of glycated serum albumin by column affinity chromatography and immunoturbidimmetry","volume":"161","author":"Reed","year":"1986","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/0168-8227(90)90005-E_BIB26","first-page":"269","article-title":"Evaluation of the measurement of blood glucose levels on dried filter paper blood spots","volume":"2","author":"Winocour","year":"1985","journal-title":"Diabetic Med."},{"key":"10.1016\/0168-8227(90)90005-E_BIB27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1464-5491.1986.tb00786.x","article-title":"The relationship between autonomic neuropathy and urinary sodium and albumin excretion in insulin-treated diabetics","volume":"3","author":"Winocour","year":"1986","journal-title":"Diabetic Med."},{"key":"10.1016\/0168-8227(90)90005-E_BIB28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0022-1759(85)90490-9","article-title":"A micro enzyme-linked immunosorbent assay for insulin antibodies in serum","volume":"76","author":"Wilkin","year":"1985","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/0168-8227(90)90005-E_BIB29","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/bmj.285.6346.916","article-title":"Diagnosis and management of diabetic autonomic neuropathy","volume":"285","author":"Ewing","year":"1982","journal-title":"Br. Med. J."},{"key":"10.1016\/0168-8227(90)90005-E_BIB30","series-title":"Report and recommendations of the San Antonio conference on diabetic neuropathy","first-page":"1000","article-title":"Consensus statement","volume":"37","author":"Asbury","year":"1988"},{"issue":"Suppl. 5A","key":"10.1016\/0168-8227(90)90005-E_BIB31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0002-9343(88)90407-X","article-title":"The Statil Study Group. Diabetic Autonomic Neuropathy \u2014 Part II. Coefficient of variations of RR variation and Valsalva manoeuvre tests","volume":"85","author":"Schumer","year":"1988","journal-title":"Am. J. Med."},{"key":"10.1016\/0168-8227(90)90005-E_BIB32","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2337\/diacare.12.10.665","article-title":"Relative clinical usefulness of glycosylated serum albumin (GSA) and fructosamine during short term improvements in glycaemic control in IDDM","volume":"12","author":"Winocour","year":"1989","journal-title":"Diabetes Care"},{"key":"10.1016\/0168-8227(90)90005-E_BIB33","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1464-5491.1989.tb01262.x","article-title":"An analysis of serial changes in glycosylated blood proteins and blood glucose profiles over one year in patients with type 1 diabetes","volume":"6","author":"Winocour","year":"1989","journal-title":"Diabetic Med."},{"key":"10.1016\/0168-8227(90)90005-E_BIB34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0026-0495(78)90121-X","article-title":"C-peptide secretion and insulin antibodies as determinants of stability in diabetes mellitus","volume":"27","author":"Yue","year":"1978","journal-title":"Metabolism"},{"key":"10.1016\/0168-8227(90)90005-E_BIB35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2362.1979.tb00916.x","article-title":"Free insulin, bound insulin, C-peptide and the metabolic control in juvenile-onset diabetics: Comparison of C-peptide secretors and non-secretors during 24 hours conventional insulin therapy","volume":"9","author":"Gerbitz","year":"1979","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/0168-8227(90)90005-E_BIB36","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/bmj.2.6200.1257","article-title":"Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes","volume":"2","author":"Madsbad","year":"1979","journal-title":"Br. Med. J."},{"key":"10.1016\/0168-8227(90)90005-E_BIB37","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1530\/acta.0.0930196","article-title":"Beta-cell function and metabolic control in insulin-treated diabetics","volume":"93","author":"Madsbad","year":"1980","journal-title":"Act. Endocrinol."},{"key":"10.1016\/0168-8227(90)90005-E_BIB38","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/BF01220642","article-title":"C-peptide in children with juvenile diabetes","volume":"12","author":"Ludvigsson","year":"1976","journal-title":"Diabetologia"},{"issue":"Suppl. 1","key":"10.1016\/0168-8227(90)90005-E_BIB39","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2337\/diab.27.1.S262","article-title":"Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of disease","volume":"27","author":"Madsbad","year":"1978","journal-title":"Diabetes"},{"key":"10.1016\/0168-8227(90)90005-E_BIB40","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/diabetes.37.7.920","article-title":"Prospective study of predictors of B-cell survival in type 1 diabetes","volume":"37","author":"Schiffrin","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/0168-8227(90)90005-E_BIB41","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/BF00252760","article-title":"Effect of strict blood glucose control on residual B-cell function in insulin-dependent diabetes","volume":"20","author":"Madsbad","year":"1981","journal-title":"Diabetologia"},{"key":"10.1016\/0168-8227(90)90005-E_BIB42","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/BF00278746","article-title":"Insulin autoantibodies are associated with islet-cell antibodies; their relation to insulin antibodies and B-cell function in diabetic children","volume":"31","author":"Ludvigsson","year":"1988","journal-title":"Diabetologia"},{"key":"10.1016\/0168-8227(90)90005-E_BIB43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00996321","article-title":"HLA-types, C-peptide and insulin antibodies in juvenile diabetes","volume":"13","author":"Ludvigsson","year":"1977","journal-title":"Diabetologia"},{"key":"10.1016\/0168-8227(90)90005-E_BIB44","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/BF00703129","article-title":"Increased reduction in fasting C-peptide is associated with islet-cell antibodies in type 1 (insulin-dependent) diabetic patients","volume":"28","author":"Marner","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/0168-8227(90)90005-E_BIB45","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diabetes.36.4.510","article-title":"Time course of islet cell antibodies and B-cell function in non-insulin-dependent stage of type 1 diabetes","volume":"36","author":"Kobayashi","year":"1987","journal-title":"Diabetes"},{"key":"10.1016\/0168-8227(90)90005-E_BIB46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF01228301","article-title":"Islet-cell antibodies and beta-cell function in insulin-dependent diabetics","volume":"18","author":"Madsbad","year":"1980","journal-title":"Diabetologia"},{"issue":"Suppl. 1","key":"10.1016\/0168-8227(90)90005-E_BIB47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2337\/diab.27.1.S265","article-title":"Islet function in diabetics with persistent islet cell antibodies","volume":"27","author":"Theophanides","year":"1978","journal-title":"Diabetes"},{"key":"10.1016\/0168-8227(90)90005-E_BIB48","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1203\/00006450-198101000-00015","article-title":"Residual B-cell function and islet-cell antibodies in diabetic children","volume":"15","author":"Crossley","year":"1981","journal-title":"Pediatr. Res."},{"key":"10.1016\/0168-8227(90)90005-E_BIB49","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/BF00453501","article-title":"Cigarette smoking as a risk factor for macroproteinuria and proliferative retinopathy in type 1 (insulin-dependent) diabetes","volume":"29","author":"Mulhauser","year":"1986","journal-title":"Diabetologia"},{"key":"10.1016\/0168-8227(90)90005-E_BIB50","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/archinte.130.6.833","article-title":"Atherosclerosis in diabetes mellitus. Correlations with serum lipid levels, adiposity and serum insulin level","volume":"130","author":"Santen","year":"1972","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/0168-8227(90)90005-E_BIB51","first-page":"46","article-title":"High serum insulin concentrations in relation to other cardiovascular risk factors in macrovascular disease of type 2 diabetics","volume":"15","author":"Standl","year":"1985","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/0168-8227(90)90005-E_BIB52","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/01.RES.36.2.319","article-title":"Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells","volume":"36","author":"Stout","year":"1975","journal-title":"Circ. Res."}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:016882279090005E?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:016882279090005E?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T06:13:30Z","timestamp":1734329610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/016882279090005E"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1990,1]]}},"alternative-id":["016882279090005E"],"URL":"https:\/\/doi.org\/10.1016\/0168-8227(90)90005-e","relation":{},"ISSN":["0168-8227"],"issn-type":[{"type":"print","value":"0168-8227"}],"subject":[],"published":{"date-parts":[[1990,1]]}}}